Matthew Nix, PhD
|
Title(s) | Specialist, Laboratory Medicine |
---|
School | School of Medicine |
---|
Address | 1001 Potrero Ave San Francisco CA 94110
|
---|
Phone | -- |
---|
vCard | Download vCard |
---|
|
|
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells. Nature. 2020 Nov 04.
Lee J, Robinson ME, Ma N, Artadji D, Ahmed MA, Xiao G, Sadras T, Deb G, Winchester J, Cosgun KN, Geng H, Chan LN, Kume K, Miettinen TP, Zhang Y, Nix MA, Klemm L, Chen CW, Chen J, Khairnar V, Wiita AP, Thomas-Tikhonenko A, Farzan M, Jung JU, Weinstock DM, Manalis SR, Diamond MS, Vaidehi N, Müschen M. PMID: 33149299.
View in: PubMed Mentions: Fields:
-
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proc Natl Acad Sci U S A. 2020 11 10; 117(45):28046-28055.
Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, Leung KK, Lim SA, Zhou XX, Hobman TC, Kortemme T, Wells JA. PMID: 33093202.
View in: PubMed Mentions: 1 Fields: Translation: HumansAnimalsCells
-
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. bioRxiv. 2020 Aug 01.
PMID: 32766586.
View in: PubMed Mentions:
-
Signalling input from divergent pathways subverts B cell transformation. Nature. 2020 07; 583(7818):845-851.
Chan LN, Murakami MA, Robinson ME, Caeser R, Sadras T, Lee J, Cosgun KN, Kume K, Khairnar V, Xiao G, Ahmed MA, Aghania E, Deb G, Hurtz C, Shojaee S, Hong C, Pölönen P, Nix MA, Chen Z, Chen CW, Chen J, Vogt A, Heinäniemi M, Lohi O, Wiita AP, Izraeli S, Geng H, Weinstock DM, Müschen M. PMID: 32699415.
View in: PubMed Mentions: Fields:
-
Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis. Leukemia. 2020 10; 34(10):2754-2765.
Sarin V, Yu K, Ferguson ID, Gugliemini O, Nix MA, Hann B, Sirota M, Wiita AP. PMID: 32123307.
View in: PubMed Mentions: 1 Fields: Translation: HumansAnimalsCells
-
Electrostatic Similarity Analysis of Human ß-Defensin Binding in the Melanocortin System. Biophys J. 2015 Nov 03; 109(9):1946-58.
PMID: 26536271.
View in: PubMed Mentions: 4 Fields: Translation: HumansCells
-
Molecular and functional analysis of human ß-defensin 3 action at melanocortin receptors. Chem Biol. 2013 Jun 20; 20(6):784-95.
PMID: 23790489.
View in: PubMed Mentions: 13 Fields: Translation: HumansAnimalsCells
-
Defining MC1R regulation in human melanocytes by its agonist a-melanocortin and antagonists agouti signaling protein and ß-defensin 3. J Invest Dermatol. 2012 Sep; 132(9):2255-62.
PMID: 22572817.
View in: PubMed Mentions: 33 Fields: Translation: HumansCells
-
Human ß-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF. Eur J Immunol. 2011 Nov; 41(11):3291-300.
Semple F, MacPherson H, Webb S, Cox SL, Mallin LJ, Tyrrell C, Grimes GR, Semple CA, Nix MA, Millhauser GL, Dorin JR. PMID: 21809339.
View in: PubMed Mentions: 43 Fields: Translation: HumansAnimalsCells
-
A -defensin mutation causes black coat color in domestic dogs. Science. 2007 Nov 30; 318(5855):1418-23.
Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, Nix MA, Kerns JA, Schmutz SM, Millhauser GL, Barsh GS. PMID: 17947548.
View in: PubMed Mentions: 120 Fields: Translation: HumansAnimalsCells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
Year | Publications |
---|
2007 | 1 | 2011 | 1 | 2012 | 1 | 2013 | 1 | 2015 | 1 | 2020 | 5 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|